Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAS40468 vs Seretide in stable asthma
NCT02094274Phase 1Completed
- Sponsor
- Almirall
- Start
- Nov 2013
- Primary completion
- May 2014
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 1, randomised, double-blind trial of LAS40468 in asthma, sponsored by Almirall. Started Nov 2013; status: completed.
02
Drugs
LAS40468
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02094274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02094274.